Rivastigmine tartrate | B3093

Rivastigmine is a cholinesterase (ChE) inhibitor that inhibits butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) with IC₅₀ values of 0.037 μM and 4.15 μM respectively. It is used for the treatment of dementia in Alzheimer's disease and Parkinson's disease.

Rivastigmine is a cholinesterase (ChE) inhibitor that inhibits butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) with IC₅₀ values of 0.037 μM and 4.15 μM respectively. It is used for the treatment of dementia in Alzheimer's disease and Parkinson's disease.

B3093 | Rivastigmine tartrate DataSheet

Alternate Name/Synonyms: (S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate; Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1); SDZ-ENA 713; ENA 713; Exelon

Appearance: White solid

Formulation:

CAS Number: 129101-54-8

Structure Available?: TRUE

Peptide sequence:

Salt Form: TRUE

Molecular Formula: C₁₈H₂₈N₂O₈

Molecular Weight: 400.42

Cell-Permeable?: True

Purity: ≥ 95%

Solubilities: ~16 mg/ml in DMSO and ethanol, ~10 mg/ml in PBS, pH 7.2, ~25 mg/ml in DMF

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: An inhibitor of butyrylcholinesterase and acetylcholinesterase

MDL Number: MFCD03700731

PubChem CID: 6918078

SMILES: CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C.C(C(C(=O)O)O)(C(=O)O)O

InChi: InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m01/s1

InChi Key: GWHQHAUAXRMMOT-MBANBULQSA-N